FDA aligned on single-arm Phase 3 study to support potential accelerated and full approvalOn track to dose first patient in Phase 3 trial in ...

For years, scientists have focused on amyloid beta buildup as the main culprit in Alzheimer’s disease, but a new study suggests the real problem might lie in a stalled protein-cutting process in the ...

Report Ocean’s recent report provides an accurate and comprehensive research analysis of the “Saudi Arabia Pompe Disease Market” with a primary focus on the present and past market conditions. The ...